Bank raises expectations for Bavarian Nordic's 2023 outlook
Danske Bank believes Bavarian Nordic is well on the way to secure another record-breaking year after having seen preliminary figures for the drugmaker’s 2022 performance on Monday.
by marketwire, translated by daniel pedersen
Bavarian Nordic’s vaccine sales have powered ahead in 2022, and Danish bank Danske Bank now predicts an even better 2023 than previously for the Danish vaccine maker.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian CFO predicts another record-breaking year ahead
For subscribers
Bavarian Nordic enters agreement with US defense department
For subscribers
